drugset / Trial / NCT00082199

Study of Aripiprazole in Subjects With Alcoholism

NCT00082199

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this clinical research study is to learn whether subjects treated with aripiprazole are able to abstain from alcohol use for a greater number of days than subjects treated with placebo. The safety of using aripiprazole will also be studied.

Timeline

Start
2004-04
Primary completion
2005-08
Completion
2005-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aripiprazole Other / unclassified 30 mg Oral

Indications